Search for: "Amgen Inc" Results 1 - 20 of 530
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2017, 9:58 pm by Patent Docs
" trilogy of BPCIA Federal Circuit cases, the Court in Amgen Inc. v. [read post]
12 Jun 2017, 9:59 pm by Patent Docs
Amgen Inc., marking the first time the Court has interpreted the Biologics Price Competition and Innovation Act ("BPCIA") for the approval of biosimilar drugs. [read post]
1 Jun 2009, 9:58 pm
By Andrew Williams -- On Monday, the Federal Circuit issued its decision in Amgen, Inc. v. [read post]
30 Aug 2018, 9:59 pm by Patent Docs
District Court Judge for the District of Delaware decided a veritable plethora of post-trial motions (by both parties) in Amgen Inc. v. [read post]
24 Jan 2013, 1:41 pm by fraudfighters
At the end of this past year, the Department of Justice announced a huge settlement it reached with Amgen Inc., one of the largest biotechnology companies in the United States. [read post]
17 Jul 2007, 8:04 pm
By Sherri Oslick -- In follow up to our earlier post, Amgen Inc. announced on Monday that it has completed its acquisition of Alantos Pharmaceuticals, providing Amgen with Alantos's DPP-IV inhibitor in clinical development (Phase 2a) for the treatment of type II diabetes, as well as its matrix metalloproteinases platform... [read post]
24 Sep 2008, 4:59 am
By Sherri Oslick -- Late last week, Magistrate Judge Mary Pat Thynge granted Amgen's motion of summary judgment of non-infringement as to all asserted claims in Amgen Inc. v. [read post]
14 Oct 2008, 4:55 am
Noonan -- On October 2, 2008, Judge William Young of the District Court of the District of Massachusetts issued his 150-page opinion in Amgen Inc. v. [read post]
11 Jul 2016, 9:59 pm by Patent Docs
By Andrew Williams -- Last year, the Federal Circuit described the Biologics Price Competition and Innovation Act ("BPCIA") as "a riddle wrapped in a mystery inside of an enigma" in the Amgen v. [read post]
9 Dec 2014, 9:43 pm by Patent Docs
By Andrew Williams -- Last year, Sandoz filed a declaratory judgment action against Amgen and Roche related to its etanercept biosimilar drug product, which it developed to compete with Amgen's Enbrel® TNF inhibitor. [read post]
19 Nov 2017, 9:05 pm by Patent Docs
Noonan -- Last month, the Federal Circuit rendered a decision in Amgen Inc. v. [read post]
11 Oct 2008, 4:45 am
Noonan -- The Federal Circuit today issued an Order, pursuant to Federal Circuit Rule 36, affirming the District Court's grant of a preliminary injunction in Amgen Inc. v. [read post]
14 Dec 2017, 9:11 pm by Patent Docs
Amgen Inc., the Supreme Court handed down its interpretation of the Biologics Price Competition and Innovation Act ("BPCIA") for the approval of biosimilar drugs. [read post]